United Therapeutics Corp. (UTHR)
469.77
+1.70
(+0.36%)
USD |
NASDAQ |
Jan 21, 16:00
469.66
-0.11
(-0.02%)
After-Hours: 20:00
United Therapeutics Cash from Investing (Quarterly): 140.90M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 14.64M |
| Gilead Sciences, Inc. | -427.00M |
| Johnson & Johnson | -- |
| Catalyst Pharmaceuticals, Inc. | 0.00 |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 562.10M |
| Cash from Financing (Quarterly) | -956.00M |
| Free Cash Flow | 1.116B |
| Free Cash Flow Per Share (Quarterly) | 7.317 |
| Free Cash Flow to Equity (Quarterly) | 346.10M |
| Free Cash Flow to Firm (Quarterly) | 348.42M |
| Free Cash Flow Yield | 4.93% |